CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 44.44%

Compliant submissions 4

Incompliant submissions 5

Total trials 9

My Organizations' Clinical Trials

Showing 300 of 430 entries

View as:

Neural Mechanisms of Disulfiram Effects

Phase: N/A Priority: Normal

NCT ID: NCT02735577 Org: User:

Start: 03/31/16 End: 10/16/20 Due: 10/16/21

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Phase: N/A Priority: Normal

NCT ID: NCT05339256 Org: User:

Start: 06/01/25 End: 09/01/26 Due: 09/01/27

The Anti-Inflammatory Effects of Exercise and Peanut Consumption

Phase: N/A Priority: Normal

NCT ID: NCT03212144 Org: User:

Start: 08/20/17 End: 12/31/19 Due: 12/31/20

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

Phase: N/A Priority: Normal

NCT ID: NCT00249483 Org: User:

Start: 10/31/99 End: 02/28/05 Due: 02/28/06

Web-based Addiction Treatment: Cultural Adaptation With American Indians

Phase: N/A Priority: Normal

NCT ID: NCT03363256 Org: User:

Start: 05/30/18 End: 09/30/20 Due: 09/30/21

Clinical Trial of AVL-3288 in Schizophrenia Patients

Phase: N/A Priority: Normal

NCT ID: NCT02978599 Org: User:

Start: 11/30/16 End: 11/02/18 Due: 11/02/19

A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression

Phase: N/A Priority: Normal

NCT ID: NCT00296699 Org: User:

Start: 03/31/05 End: - Due: -

Training Providers to Conduct PRIDES-sSA

Phase: N/A Priority: Normal

NCT ID: NCT03610750 Org: User:

Start: 12/01/18 End: 04/30/25 Due: 04/30/26

Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site

Phase: N/A Priority: Normal

NCT ID: NCT00251043 Org: User:

Start: 09/30/05 End: 04/30/10 Due: 04/30/11

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

Phase: N/A Priority: Normal

NCT ID: NCT00742573 Org: User:

Start: 08/31/08 End: 01/10/14 Due: 01/10/15

Appetite-Related Brain Activity in Women With Anorexia Nervosa

Phase: N/A Priority: Normal

NCT ID: NCT00344656 Org: User:

Start: 10/31/04 End: 10/31/10 Due: 10/31/11

Optimizing Electroconvulsive Therapy for Depression

Phase: N/A Priority: Normal

NCT ID: NCT00045916 Org: User:

Start: 02/28/01 End: 12/31/06 Due: 12/31/07

Modafinil for Treatment of Fatigue in ALS Patients

Phase: N/A Priority: Normal

NCT ID: NCT00614926 Org: User:

Start: 06/30/06 End: 07/31/08 Due: 07/31/09

Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression

Phase: N/A Priority: Normal

NCT ID: NCT02750631 Org: User:

Start: 04/30/14 End: 07/31/17 Due: 07/31/18

Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal

Phase: N/A Priority: Normal

NCT ID: NCT05114460 Org: User:

Start: 11/01/21 End: 10/29/24 Due: 10/29/25

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00142961 Org: User:

Start: 10/31/05 End: 01/31/07 Due: 01/31/08

Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00316316 Org: User:

Start: 03/31/06 End: 03/31/10 Due: 03/31/11

Combination Treatment Study for Memory Impairment and Depression

Phase: N/A Priority: Normal

NCT ID: NCT01658228 Org: User:

Start: 09/30/11 End: 01/31/16 Due: 01/31/17

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

Phase: N/A Priority: Normal

NCT ID: NCT01951118 Org: User:

Start: 10/31/13 End: 05/31/19 Due: 05/31/20

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

Phase: N/A Priority: Normal

NCT ID: NCT00577408 Org: User:

Start: 09/30/07 End: 08/31/11 Due: 08/31/12

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder

Phase: N/A Priority: Normal

NCT ID: NCT03902613 Org: User:

Start: 02/07/19 End: 08/01/19 Due: 08/01/20

Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00739765 Org: User:

Start: 04/30/08 End: 03/31/14 Due: 03/31/15

Ketamine Treatment Effects on Synaptic Plasticity in Depression

Phase: N/A Priority: Normal

NCT ID: NCT04091971 Org: User:

Start: 10/09/20 End: 05/01/22 Due: 05/01/23

Risks and Benefits of Naloxone Prescribing

Phase: N/A Priority: Normal

NCT ID: NCT02535494 Org: User:

Start: 07/31/14 End: 12/31/21 Due: 12/31/22

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Phase: N/A Priority: Normal

NCT ID: NCT04056182 Org: User:

Start: 09/01/19 End: 01/29/21 Due: 01/29/22

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Neural Mechanisms of Disulfiram Effects	NCT02735577	New York State Psychiatric Institute	user2@example.com	None	2016-03-31	2020-10-16	2021-10-16	-	-	2025-07-14
Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual	NCT05339256	New York State Psychiatric Institute	user2@example.com	None	2025-06-01	2026-09-01	2027-09-01	-	-	2025-07-14
The Anti-Inflammatory Effects of Exercise and Peanut Consumption	NCT03212144	New York State Psychiatric Institute	user2@example.com	None	2017-08-20	2019-12-31	2020-12-31	-	-	2025-07-14
Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals	NCT00249483	New York State Psychiatric Institute	user2@example.com	None	1999-10-31	2005-02-28	2006-02-28	-	-	2025-07-14
Web-based Addiction Treatment: Cultural Adaptation With American Indians	NCT03363256	New York State Psychiatric Institute	user2@example.com	None	2018-05-30	2020-09-30	2021-09-30	-	-	2025-07-14
Clinical Trial of AVL-3288 in Schizophrenia Patients	NCT02978599	New York State Psychiatric Institute	user2@example.com	None	2016-11-30	2018-11-02	2019-11-02	-	-	2025-07-14
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression	NCT00296699	New York State Psychiatric Institute	user2@example.com	None	2005-03-31	-	-	-	-	2025-07-14
Training Providers to Conduct PRIDES-sSA	NCT03610750	New York State Psychiatric Institute	user2@example.com	None	2018-12-01	2025-04-30	2026-04-30	-	-	2025-07-14
Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Site	NCT00251043	New York State Psychiatric Institute	user2@example.com	None	2005-09-30	2010-04-30	2011-04-30	-	-	2025-07-14
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics	NCT00742573	New York State Psychiatric Institute	user2@example.com	None	2008-08-31	2014-01-10	2015-01-10	-	-	2025-07-14
Appetite-Related Brain Activity in Women With Anorexia Nervosa	NCT00344656	New York State Psychiatric Institute	user2@example.com	None	2004-10-31	2010-10-31	2011-10-31	-	-	2025-07-14
Optimizing Electroconvulsive Therapy for Depression	NCT00045916	New York State Psychiatric Institute	user2@example.com	None	2001-02-28	2006-12-31	2007-12-31	-	-	2025-07-14
Modafinil for Treatment of Fatigue in ALS Patients	NCT00614926	New York State Psychiatric Institute	user2@example.com	None	2006-06-30	2008-07-31	2009-07-31	-	-	2025-07-14
Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression	NCT02750631	New York State Psychiatric Institute	user2@example.com	None	2014-04-30	2017-07-31	2018-07-31	-	-	2025-07-14
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal	NCT05114460	New York State Psychiatric Institute	user2@example.com	None	2021-11-01	2024-10-29	2025-10-29	-	-	2025-07-14
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder	NCT00142961	New York State Psychiatric Institute	user2@example.com	None	2005-10-31	2007-01-31	2008-01-31	-	-	2025-07-14
Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder	NCT00316316	New York State Psychiatric Institute	user2@example.com	None	2006-03-31	2010-03-31	2011-03-31	-	-	2025-07-14
Combination Treatment Study for Memory Impairment and Depression	NCT01658228	New York State Psychiatric Institute	user2@example.com	None	2011-09-30	2016-01-31	2017-01-31	-	-	2025-07-14
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly	NCT01951118	New York State Psychiatric Institute	user2@example.com	None	2013-10-31	2019-05-31	2020-05-31	-	-	2025-07-14
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone	NCT00577408	New York State Psychiatric Institute	user2@example.com	None	2007-09-30	2011-08-31	2012-08-31	-	-	2025-07-14
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder	NCT03902613	New York State Psychiatric Institute	user2@example.com	None	2019-02-07	2019-08-01	2020-08-01	-	-	2025-07-14
Effectiveness of Three Different Psychotherapies for Chronic Post-Traumatic Stress Disorder	NCT00739765	New York State Psychiatric Institute	user2@example.com	None	2008-04-30	2014-03-31	2015-03-31	-	-	2025-07-14
Ketamine Treatment Effects on Synaptic Plasticity in Depression	NCT04091971	New York State Psychiatric Institute	user2@example.com	None	2020-10-09	2022-05-01	2023-05-01	-	-	2025-07-14
Risks and Benefits of Naloxone Prescribing	NCT02535494	New York State Psychiatric Institute	user2@example.com	None	2014-07-31	2021-12-31	2022-12-31	-	-	2025-07-14
Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment	NCT04056182	New York State Psychiatric Institute	user2@example.com	None	2019-09-01	2021-01-29	2022-01-29	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance